ONO Receives a Manufacturing and Marketing Approval of Adlumiz® (Anamorelin), a Ghrelin Receptor Agonist for the Treatment of Cancer Cachexia in Japan

    NEXT STORY
    Respiratory Ventilator Tester Market Forecast to 2027 – COVID-19 Impact and Global Analysis By Product ; Application ; End-user and Geography
    PREV STORY
    Immutep Quarterly Activities Report
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    BioTelemetry, Inc. Announces Receipt of Antitrust Clearance for its Acquisition of LifeWatch AG

    MALVERN, Pa. and ZUG, Switzerland , May 08, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. ...

    author_avatar
    NASDAQ Market News

    Aptevo Therapeutics to Present at the 30th Annual ROTH Conference

    SEATTLE, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Aptevo Therapeutics Inc. (Nasdaq:APVO), a biotechnology company ...

    author_avatar
    NASDAQ Market News

    North American Partners in Anesthesia Expands Anesthesia Services to Lawrence General Hospital in Lawrence, Massachusetts

    author_avatar
    NASDAQ Market News